GLP-1 Management

Monitor body composition changes throughout GLP-1 treatment programs

GLP-1 medications such as Ozempic®, Wegovy® and Mounjaro® are transforming weight management and metabolic healthcare. As these therapies continue to expand across medical wellness, obesity management and preventative healthcare programs, monitoring body composition is becoming increasingly important. InBody body composition analyzers provide healthcare professionals with objective measurements of muscle mass, body fat, visceral fat, hydration and muscle health to support healthier and more sustainable patient outcomes throughout GLP-1 treatment.

Why is body composition analysis an effective tool for GLP-1 management?

In less than 60 seconds, an InBody Test provides a comprehensive Result Sheet to help healthcare professionals:

  • Monitor fat loss versus skeletal muscle loss throughout GLP-1 treatment
  • Assess visceral fat reduction and improvements in cardiometabolic health
  • Evaluate hydration balance and inflammation through segmental water analysis
  • Identify sarcopenia risk and monitor muscle health indicators
  • Support healthy aging and long-term weight management outcomes
  • Improve patient engagement with measurable and trackable health data

Key Assessments

Muscle-Fat & Segmental Lean Analysis
Visceral Fat Analysis
ECW/TBW Analysis
Sarcopenia Parameters
Hand Grip Strength with InGrip
Phase Angle
IBC-GLP-1 Management-hero[66]
IBC-muscle icon

Monitor body composition changes beyond body weight alone

Body weight alone does not provide a complete understanding of patient progress during GLP-1 treatment.

Muscle-Fat Analysis helps healthcare professionals evaluate changes in skeletal muscle mass and body fat mass throughout weight management programs.

Monitoring skeletal muscle mass is especially important during rapid weight reduction, as preserving lean mass supports:

  • Metabolic health
  • Strength and mobility
  • Healthy aging
  • Long-term weight maintenance
  • Overall physical function

Segmental Lean Analysis also provides insight into muscle distribution throughout the body, helping support:

  • Functional wellness assessments
  • Resistance training interventions
  • Sarcopenia monitoring
  • Long-term treatment planning

By evaluating muscle and fat balance together, healthcare professionals can support healthier and more sustainable body composition outcomes.

IBC-fat icon

Assess cardiometabolic health improvements

Visceral fat is the fat stored deep within the abdominal cavity surrounding the internal organs.

Elevated visceral fat levels are strongly associated with increased risk for:

  • Type 2 Diabetes
  • Cardiovascular Disease
  • Hypertension
  • Metabolic Syndrome
  • Chronic inflammation

GLP-1 therapies are often used to support metabolic health improvements, making visceral fat monitoring an important component of treatment programs.

Monitoring visceral fat allows healthcare professionals to:

  • Track metabolic improvements
  • Support preventative healthcare initiatives
  • Improve patient education and engagement
  • Monitor obesity-related health risk reduction

With InBody, visceral fat can be measured quickly and non-invasively in under 60 seconds.

IBC-body water icon

Assess hydration balance and physiological changes

Extracellular Water (ECW) is the water found outside of the body’s cells, while Total Body Water (TBW) reflects overall hydration status.

Changes in ECW/TBW balance may be associated with:

  • Inflammation
  • Fluid imbalance
  • Nutritional status
  • Recovery trends
  • Overall wellness changes

Segmental water analysis provides healthcare professionals with objective insight into hydration balance and physiological changes occurring throughout GLP-1 treatment programs.

Monitoring ECW/TBW can support:

  • Wellness monitoring
  • Hydration assessments
  • Recovery evaluations
  • Long-term patient management
  • Healthy aging initiatives
IBC-sarco icon

Monitor muscle health and sarcopenia risk

Sarcopenia is the progressive loss of muscle mass and strength associated with aging, inactivity or chronic disease.

As GLP-1 therapies become increasingly common across obesity management and aging populations, monitoring muscle health and sarcopenia risk is becoming more important.

The InBody Result Sheet includes sarcopenia-related parameters that help evaluate:

  • Skeletal Muscle Mass
  • Appendicular Lean Mass
  • Muscle distribution
  • Muscle-to-weight relationships
  • Functional muscle health indicators

These measurements can support:

  • Healthy aging initiatives
  • Medical weight management programs
  • Resistance training interventions
  • Functional wellness assessments
  • Long-term mobility preservation

Monitoring muscle health throughout GLP-1 treatment helps support safer and more sustainable patient outcomes.

IBC- grip icon

Assess functional strength and longevity markers

Hand grip strength is increasingly recognized as an important indicator of:

  • Functional strength
  • Mobility
  • Frailty risk
  • Healthy aging
  • Sarcopenia risk
  • Overall health outcomes

The InGrip Handheld Dynamometer provides quick and objective grip strength assessment that complements body composition analysis and sarcopenia monitoring.

Combined with InBody assessments, InGrip helps healthcare professionals evaluate:

  • Functional muscle performance
  • Strength preservation during weight loss
  • Sarcopenia risk
  • Rehabilitation progress
  • Long-term wellness trends

Grip strength assessment adds an important functional measurement beyond muscle mass alone, helping provide a more comprehensive understanding of patient health and physical function.

IBC-cell icon

Monitor cellular health and overall wellness

Phase Angle is a measurement associated with cellular integrity and overall cellular health.

Healthy cells maintain strong cell membranes and balanced intracellular and extracellular water distribution.

Changes in Phase Angle may be associated with:

  • Nutritional status
  • Muscle quality
  • Recovery trends
  • Cellular health
  • Overall wellness

With InBody technology, healthcare professionals can assess cellular health quickly and non-invasively throughout GLP-1 treatment programs.

Recommended Models

Innovative Health

inbody 580

InBody 580

Body Composition Analyzer

Best for wellness clinics, pharmacies and GLP-1 treatment programs
Test results in 30 seconds

Medical Grade

InBody 770 - 45side (high res)

InBody 770

Body Composition Analyzer

Best for advanced medical wellness and obesity management applications
Test results in 60 seconds

Comprehensive Analysis

970 front

InBody 970S

Body Composition Analyzer

Best for clinical, medical and research environments
Test results in 30 seconds

Grip Strength

ingrip-hero[17]

InGrip

Handheld Dynamometer

Best for grip strength assessment, sarcopenia monitoring and healthy aging evaluations

Leverage InBody technology
to support healthier GLP-1 outcomes

Monitor muscle health, body composition and long-term wellness throughout GLP-1 treatment programs with InBody body composition analysis and InGrip strength assessment technology.

The InBody Result Sheet Guide

How to read, understand, and use the InBody Result Sheet for your business.

InBody and the Immune System E-Book

Download our e-book and learn about the importance of a healthy body composition for the immune system